General Information of the Compound
Compound ID
CP0094839
Compound Name
CHEBI:4638
    Show/Hide
Synonyms
1,1-diphenyl-4-piperidin-1-ylbutan-1-ol
1,1-diphenyl-4-piperidin-1-ylbutan-1-ol hydrochloride
Alpha,alpha-Diphenyl-1-piperidinebutanol
Avomol
Defenidol
Difenidol
Difenidol HCl
Difenidolo
Difenidolo [DCIT]
Difenidolum
Difenidolum [INN-Latin]
Diphenidol
Diphenidol (USAN/INN)
Diphenidol [USAN:BAN]
Diphenyl(3-(1-piperidyl)propyl)carbinol
Nometic
SK&F-478
SK-478
SKF 478
Vontrol
    Show/Hide
Structure
Formula
C21H27NO
Molecular Weight
309.453
Canonical SMILES
OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C21H27NO/c23-21(19-11-4-1-5-12-19,20-13-6-2-7-14-20)15-10-18-22-16-8-3-9-17-22/h1-2,4-7,11-14,23H,3,8-10,15-18H2
    Show/Hide
InChIKey
OGAKLTJNUQRZJU-UHFFFAOYSA-N
CAS
972-02-1
Physicochemical Property
logP
4.1886
Rotatable Bonds
6
Heavy Atom Count
23
Polar Areas
23.47
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 3055
SID: 15420107
ChEMBL ID
CHEMBL936
DrugBank ID
DB01231
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00817, Cytochrome P450 2D6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000023 BTI-Tn-5B1-4 Trichoplusia ni (Cabbage looper)  1
1
IC50 = 326.3 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Potency = 125.9 nM
Clinical Information about the Compound
Drug 1 ( Diphenidol )
Drug Name Diphenidol
Indication
Nausea
Approved
Target(s)
Muscarinic acetylcholine receptor M4 (CHRM4)
Antagonist